Safety considerations when prescribing immunosuppression medication to pregnant women.
about
Challenges and treatment options for rheumatoid arthritis during pregnancy.Maternal and neonatal outcomes in pregnant women with autoimmune diseases in Pavia, Italy.Treatment of severe non-infectious uveitis in high-risk conditions (Part I): pregnancy and malignancies, management and safety issues.Therapeutic options in neuromyelitis optica spectrum disorders.The Use of Cyclosporine A in Rheumatology: a 2016 Comprehensive Review.Pharmacologic Treatment of Noninfectious Uveitis.Safety of Immunomodulators and Anti-TNF Therapy in Pregnancy.Premedication of pregnant patients with history of iodinated contrast allergy.
P2860
Q30249730-761F6EC0-8F72-460D-A363-1E10AC02F10EQ35871745-604C5285-B0AE-48C6-BE77-055D13224ACAQ38464355-E82D01B8-8247-4BEE-98CC-7028B56DEE7EQ38721559-7A453195-93BC-4A9D-B938-BA218EC14F66Q38925320-02492542-91F8-449C-911D-080905796D33Q40450258-FF341582-F937-4412-A453-80C7F572A999Q41601749-D872B8A7-ED44-4634-9D8C-E63C3AD05F2BQ48146481-BB576906-92B3-4A38-84EC-E91E467921DC
P2860
Safety considerations when prescribing immunosuppression medication to pregnant women.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Safety considerations when prescribing immunosuppression medication to pregnant women.
@en
type
label
Safety considerations when prescribing immunosuppression medication to pregnant women.
@en
prefLabel
Safety considerations when prescribing immunosuppression medication to pregnant women.
@en
P2860
P1476
Safety considerations when prescribing immunosuppression medication to pregnant women
@en
P2093
Rolando Cimaz
P2860
P304
P356
10.1517/14740338.2014.951326
P407
P577
2014-09-05T00:00:00Z